Louise Maymann Nitze

Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study

Quentin M. Anstee, Tina Landsvig Berentzen, Louise Maymann Nitze et al. · The Lancet Regional Health - Europe · 2023 · 94 citations · Full text

Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer

Louise Maymann Nitze, Elisabeth D. Galsgaard, Nanni Din et al. · Breast Cancer Research and Treatment · 2013 · 35 citations · Full text

Pituitary Hormone Prolactin, Breast Oncology, Prl Expression +13

Collagen Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through Osteoclast-Associated Receptor

Heidi S. Schultz, Louise Maymann Nitze, Louise Zeuthen et al. · The Journal of Immunology · 2015 · 35 citations · Full text

Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis

Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær et al. · Nature Medicine · 2025 · 30 citations · Full text

FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial

Vincent Wai‐Sun Wong, Quentin M. Anstee, Louise Maymann Nitze et al. · EClinicalMedicine · 2023 · 29 citations · Full text